Infliximab

In the US, Infliximab (infliximab systemic) is a member of the following drug classes: antirheumatics, TNF alfa inhibitors and is used to treat Ankylosing Spondylitis, Behcet's Disease, Bullous Pemphigoid, Celiac Disease, Cogan's Syndrome, Crohn's Disease - Acute, Crohn's Disease - Maintenance, Giant Cell Arteritis, Juvenile Idiopathic Arthritis, Kawasaki Disease, Neurosarcoidosis, Pemphigoid, Pemphigus, Polychondritis, Psoriasis, Psoriatic Arthritis, Pulmonary Fibrosis, Pyoderma Gangrenosum, Rheumatoid Arthritis, SAPHO Syndrome, Sarcoidosis, Sjogren's Syndrome, Subcorneal Pustular Dermatosis, Toxic Epidermal Necrolysis, Ulcerative Colitis and Uveitis.

US matches:

• Infliximab


• Infliximab Intravenous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L04AA12,L04AB02

CAS registry number (Chemical Abstracts Service)

0170277-31-3

Chemical Formula

C6428-H9912-N1694-O1987-S46

Molecular Weight

144190

Therapeutic Categories

Anti-inflammatory agent

Disease-modifying antirheumatic drug, DMARD

Biological response modifier, BRM

Immunomodulator

Monoclonal antibody

Tumor necrosis factor alpha (TNF-α) inhibitor

Chemical Name

Immunglobulin G (human-mouse monoclonal cA2 heavy chain anti-human tumor necrosis factor), disulfide with human-mouse monoclonal cA2 light chain, dimer (WHO)

Foreign Names

• Infliximabum (Latin)
• Infliximab (German)
• Infliximab (French)
• Infliximab (Spanish)

Generic Names

• Infliximab (OS: USAN, BAN, DCF)
• cA2 (IS)
• CenTNF (IS)

Brand Names

• Remicade
  Centocor, Austria; Centocor, Czech Republic; Centocor, Greece; Centocor, Hungary; Centocor, Israel; Centocor, Iceland; Centocor, Luxembourg; Centocor, Netherlands; Centocor, Slovenia; Centocor, Tunisia; Centocor, United States; Centocor B.V, Denmark; Centocor-NL, Italy; Essex, Germany; Essex Chemie, Switzerland; Janssen, Hong Kong; Kirby, Ecuador; Plough, Colombia; Schering, Argentina; Schering, Georgia; Schering-Plough, Australia; Schering-Plough, Belgium; Schering-Plough, Canada; Schering-Plough, Chile; Schering-Plough, Costa Rica; Schering-Plough, Dominican Republic; Schering-Plough, Spain; Schering-Plough, Finland; Schering-Plough, France; Schering-Plough, United Kingdom; Schering-Plough, Guatemala; Schering-Plough, Honduras; Schering-Plough, Croatia (Hrvatska); Schering-Plough, Ireland; Schering-Plough, Mexico; Schering-Plough, Malaysia; Schering-Plough, Nicaragua; Schering-Plough, Norway; Schering-Plough, New Zealand; Schering-Plough, Oman; Schering-Plough, Panama; Schering-Plough, Peru; Schering-Plough, Philippines; Schering-Plough, Portugal; Schering-Plough, Romania; Schering-Plough, Serbia; Schering-Plough, Russian Federation; Schering-Plough, Sweden; Schering-Plough, Singapore; Schering-Plough, Slovakia; Schering-Plough, El Salvador; Schering-Plough, Thailand; Schering-Plough, Turkey; Schering-Plough, Venezuela; Tanabe, Indonesia; Tanabe Mitsubishi, Japan; Xian-Janssen, China



• Revellex
  Schering-Plough, South Africa

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.